CpG-Based Nanovaccines for Cancer Immunotherapy
Wenqiang Chen,1 Mingxia Jiang,1 Wenjing Yu,1 Zhiwei Xu,1 Xinyue Liu,1 Qingmiao Jia,1 Xiuwen Guan,1– 3 Weifen Zhang1– 3 1College of Pharmacy, Weifang Medical University, Weifang, 261053, People’s Republic of China; 2Collaborative Innovation Center for Target Drug Delivery System, Weifang Medical Univ...
Guardado en:
Autores principales: | Chen W, Jiang M, Yu W, Xu Z, Liu X, Jia Q, Guan X, Zhang W |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/347926a805d042829941f9b4fa3a92a9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Antigen-Conjugated Silica Solid Sphere as Nanovaccine for Cancer Immunotherapy
por: Dong Y, et al.
Publicado: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice
por: Zhao Y, et al.
Publicado: (2020) -
Mannose-Modified Liposome Co-Delivery of Human Papillomavirus Type 16 E7 Peptide and CpG Oligodeoxynucleotide Adjuvant Enhances Antitumor Activity Against Established Large TC-1 Grafted Tumors in Mice [Corrigendum]
por: Zhao Y, et al.
Publicado: (2021) -
Induction of Robust Immune Responses by CpG-ODN-Loaded Hollow Polymeric Nanoparticles for Antiviral and Vaccine Applications in Chickens
por: Lin SY, et al.
Publicado: (2020) -
Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
por: Ting Cai, et al.
Publicado: (2021)